Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Equities research analysts at Leerink Partnrs dropped their Q4 2024 earnings per share estimates for United Therapeutics in a ...

Leerink Partnrs dropped their FY2024 earnings per share estimates for shares of United Therapeutics in a research report ...

United Therapeutics (UTHR) shares soared 4.9% in the last trading session to close at $370.74. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

Factor, the market leader in Integrated Law, today announced its acquisition of Theory and Principle, a specialized legal technology design and development agency. The purchase advances Factor's ...

AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of ...

The kidney transplant rejection prophylaxis market is projected to experience steady growth, driven by the introduction of innovative therapi ...

According to the company, the suffix “-mod” in urcosimod denotes its classification as a modulator of key inflammatory and ...

PureTech Founded Entity Seaport Therapeutics Announces Publication of New Research Demonstrating Increased Lymphatic Transport with Glyph Platform ...

Juniper Networks, , a leader in secure, AI-Native Networking, today announced new additions to its leading wired access portfolio that enable companies of all sizes to scale their IT operations, ...

Extreme Networks, Inc. , a leader in AI-powered automation for networking, today announced new E-Rate eligible solutions for K-12 schools and public libraries in the U.S, including the company's ...